# OnCo record nct02586857 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02586857/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02586857", "NCT02586857" ;
  schema:name "A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"@en ;
  schema:description "A phase 1/2 trial of ACP-196 in glioma & glioblastoma, run by Acerta Pharma BV, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02586857/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02586857> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2016-01-25" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .